Clinical Trial

Generative Artificial Intelligence Intervention and Individual Psychological Counseling on Emotional Distress in Young Adults

Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled trial aims to evaluate the effectiveness of an AI-based mental health chatbot, Emohaa, in reducing symptoms of depression, anxiety, insomnia, and academic burnout among young adults experiencing emotional distress. A total of 222 participants will be randomly assigned to one of three groups: (1) AI chatbot intervention, (2) traditional counseling, or (3) waitlist control. The study spans six time points from baseline through one-month follow-up. Primary and secondary outcomes will be measured via validated self-report questionnaires. The intervention is delivered entirely online through a WeChat-integrated platform, ensuring high accessibility and scalability.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-24.
Status change: Not Yet Recruiting → Completed 2026-05-24
Trial Details
NCT Number NCT06992180
Lead Sponsor Central University of Finance and Economics, China
Collaborators: Beijing Normal University, China Agricultural University, Qinghai University
Conditions Depression, Anxiety
Enrollment 222 participants
Start Date 2025-05-20
Primary Completion 2025-08-30 (estimated)
Study Completion 2025-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-28